Terug
26
4
Ook genoteerd als
UMICF
OTC
Dagbereik
€ 4,52
€ 4,58
52-Weeksbereik
€ 1,96
€ 6,43
Volume
116
50D / 200D Gem.
€ 5,42
/
€ 4,57
Vorige Slotkoers
€ 4,33
Koershistorie
Financiële Trends
Sectorvergelijking
vs Industrials sector mediaan (893 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 11,9 | 14,4 |
| P/B | 2,0 | 1,9 |
| ROE % | 17,7 | 11,4 |
| Net Margin % | 2,0 | 6,5 |
| Rev Growth 5Y % | -6,2 | 8,4 |
| D/E | 1,3 | 0,6 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,00
€ 0,00 – € 0,00
|
4,4 B | 0 |
| FY2029 |
€ 0,47
€ 0,46 – € 0,48
|
4,2 B | 1 |
| FY2028 |
€ 0,54
€ 0,53 – € 0,56
|
4 B | 1 |
Belangrijkste Punten
Revenue declined -6,21% annually over 5 years
ROE of 17,69% — decent returns on equity
Generating 321,49M in free cash flow
P/E of 11,91 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 31,49%
Cash machine — converts 87,05% of earnings into free cash flow
Groei
Revenue Growth (5Y)
-6,21%
Revenue (1Y)25,28%
Earnings (1Y)N/A
FCF Growth (3Y)42,68%
Kwaliteit
Return on Equity
17,69%
ROIC14,58%
Net Margin1,98%
Op. Margin5,31%
Veiligheid
Debt / Equity
1,27
Current Ratio1,35
Interest Coverage6,87
Waardering
P/E Ratio
11,91
P/B Ratio1,96
EV/EBITDA5,75
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25,28% | Revenue Growth (3Y) | 0,94% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -2,07% |
| Revenue Growth (5Y) | -6,21% | Earnings Growth (5Y) | -12,11% |
| Profitability | |||
| Revenue (TTM) | 18,61B | Net Income (TTM) | 369,32M |
| ROE | 17,69% | ROA | 3,91% |
| Gross Margin | 7,21% | Operating Margin | 5,31% |
| Net Margin | 1,98% | Free Cash Flow (TTM) | 321,49M |
| ROIC | 14,58% | FCF Growth (3Y) | 42,68% |
| Safety | |||
| Debt / Equity | 1,27 | Current Ratio | 1,35 |
| Interest Coverage | 6,87 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 11,91 | P/B Ratio | 1,96 |
| P/S Ratio | 0,24 | PEG Ratio | -0,09 |
| EV/EBITDA | 5,75 | Dividend Yield | 0,01% |
| Market Cap | 4,40B | Enterprise Value | 5,68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18,61B | 14,85B | 18,27B | 25,44B | 24,05B |
| Net Income | 369,32M | -1,48B | 385,08M | 569,88M | 618,96M |
| EPS (Diluted) | 0,38 | -1,54 | 0,40 | 0,59 | 0,64 |
| Gross Profit | 1,34B | 2,21B | 1,52B | 1,67B | 1,57B |
| Operating Income | 987,33M | -1,26B | 590,68M | 818,67M | 878,94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9,46B | 9,41B | 9,97B | 9,94B | 9,05B |
| Total Liabilities | 7,18B | 7,49B | 6,27B | 6,38B | 5,88B |
| Shareholders' Equity | 2,24B | 1,94B | 3,66B | 3,52B | 3,11B |
| Total Debt | 2,84B | 3,45B | 2,75B | 2,35B | 2,16B |
| Cash & Equivalents | 1,56B | 2,01B | 1,52B | 1,24B | 1,19B |
| Current Assets | 5,73B | 5,61B | 5,81B | 6,55B | 5,94B |
| Current Liabilities | 4,25B | 4,35B | 3,60B | 4,13B | 3,48B |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#905 of 1052
#623 of 670
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026